Rate My Professor Lucinda Krause

Dr. Lucinda Krause is a Senior Lecturer in Physiology at Monash University's Biomedicine Discovery Institute, within the Faculty of Medicine, Nursing and Health Sciences. She obtained her PhD from the Department of Biochemistry and Molecular Biology at Monash University in 2008, investigating the mechanism of albuminuria associated with cardiovascular disease. In 2009, she joined the Department of Physiology as a Postdoctoral Research Fellow and has since progressed through various academic roles, culminating in her promotion to Senior Lecturer in 2023. Krause contributes to teaching in several units, including Body Systems Physiology (PHY2042), Cardiovascular Biology and Disease (BMS5006), and Hormones and Reproduction (PHY3181). She has also served as Chief Investigator D on NHMRC Ideas Grants, such as project GNT2012552 exploring sex-specific mechanisms in cardiovascular research.

Her research focuses on sex differences in the regulation of arterial pressure, particularly the involvement of the renin-angiotensin system and its contribution to differences in cardiovascular disease development between men and women. Key areas include hypertension, ageing, kidney function, hypoxia, and renal sympathetic nerves, with ongoing projects such as 'Sex-differences in cellular aging and cardiovascular disease: Role of the AngIV/IRAP axis' (2022–2025). Krause has received notable awards, including the Australian Postgraduate Award (2005), Best Early Career Presentation Award at the RAS Club New Horizons conference (2010), Foundation for High Blood Pressure Research Young Investigator Travel Awards (2012 and 2014), and International Society of Hypertension New Investigator of the Month (September 2014). Selected publications include 'Considering sex as a biological variable in basic and clinical studies: An endocrine society scientific statement' (Endocrine Reviews, 2021), 'In Aged Females, the Enhanced Pressor Response to Angiotensin II Is Attenuated By Estrogen Replacement via an Angiotensin Type 2 Receptor-Mediated Mechanism' (Hypertension, 2021), 'Relaxin Attenuates Organ Fibrosis via an Angiotensin Type 2 Receptor Mechanism in Aged Hypertensive Female Rats' (Kidney360, 2021), 'Renal functional effects of the highly selective AT2R agonist, β-Pro7 Ang III, in normotensive rats' (Clinical Science, 2020), and 'Impact of choice of kinetic model for the determination of transcutaneous FITC-sinistrin clearance in rats with streptozotocin-induced type 1 diabetes' (Clinical and Experimental Pharmacology and Physiology, 2020).